BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2020
View Archived Issues
New regeneration factor for muscle cells
Read More
Escape reports phase I data on oral S1P5 receptor agonist ESB-1609
Read More
Novel potent NAMPT inhibitor reduces tumor growth in mouse model of TNBC
Read More
SM-09419 shows promising antitumor activity in preclinical models of hematologic malignancies
Read More
New humanized transgenic mouse model of FNAIT
Read More
Apellis announces positive topline data from phase III PEGASUS study of pegcetacoplan in PNH
Read More
SX-682 blocks key immunosuppressive tumor cells
Read More
Galapagos synthesizes SIK1, SIK2 and SIK3 inhibitors
Read More
Canakkale Onsekiz Mart Ueniversitesi divulges EEF2K inhibitors
Read More
Georgia State University discloses compounds for bacterial infections
Read More
Scripps Research Institute presents myosin-2 ATPase activity inhibitors
Read More
Nanchang University identifies antibodies for enterovirus 71 infections
Read More
Cobra genome may yield new antivenoms, venom-based drugs
Read More
New CD7-negative T cells presented as potential treatment for CD7-positive cancer
Read More
CStone begins phase III study of CS-1001 for advanced esophageal squamous cell carcinoma
Read More
Takeda opens recruitment in phase II study of TAK-079 for generalized myasthenia gravis
Read More
Cerevel starts phase III study of tavapadon in early Parkinson's disease
Read More
Dosing begins in phase IIa trial of avasopasem manganese to reduce radiation-induced esophagitis
Read More
CureVac reports interim phase I data on prophylactic mRNA-based rabies vaccine CV-7202
Read More
